Hot topics for both consumers and webmarketers on WebmasterRadio.FM
Every Wednesday, 5PM Eastern.
January 12, 2007, Newsletter Issue #37: Previously Completed ALS Research
1
Tip of the Week
As written on the ALS Association's Drug Development Update Web site, a wide assortment of clinical research trials were completed in the hopes of finding a cure for ALS.
The creators of a third drug called Xaliproden, which showed promise in clinical research trials in the European Union, withdrew their application for FDA approval. Two previous trials showed Xaliproden reduced disease progression, improved pulmonary function, and protected nerve cell membranes. However, the application for approval was withdrawn because the company felt more research had to be completed.
2
About LifeTips
Now one of the top on-line publishers in the world, LifeTips offers
tips to millions of monthly visitors. Our mission mission is to make
your life smarter, better, faster and wiser. Expert writers earn dough
for what they know. And exclusive sponsors in each niche topic help us
make-it-all happen.
